These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7608623)

  • 1. [A case of well differentiated mucinous cystadenocarcinoma of the ovary with intratumoral DNA heterogeneity].
    Takahashi Y; Yamade I; Mitsuno N; Yokoe Y; Takenaka A; Noda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jun; 47(6):569-72. PubMed ID: 7608623
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relation between DNA content in ovarian cystadenoma and its pathohistology].
    Sun ZC
    Zhonghua Fu Chan Ke Za Zhi; 1993 Dec; 28(12):731-3, 760-1. PubMed ID: 8137645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
    Liu C; Zhao Y; Sun X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous adenocarcinoma of the ovary.
    Sholi A; Martino MA; Pirigyi M; Rosenblum NG; Markman M; Peterson CS; Bradbury AR; Morris GJ
    Semin Oncol; 2010 Aug; 37(4):314-20. PubMed ID: 20816501
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].
    Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S
    Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic significance of cellular DNA content and AgNOR count in ovarian cystadenoma].
    Lu XL; Yi WM; Wang LF
    Ai Zheng; 2003 Jan; 22(1):62-5. PubMed ID: 12561439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection.
    Takeshima Y; Amatya VJ; Daimaru Y; Nakayori F; Nakano T; Inai K
    Hum Pathol; 2001 Nov; 32(11):1203-8. PubMed ID: 11727259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of decreased mitochondrial DNA content with ovarian cancer progression.
    Wang Y; Liu VW; Xue WC; Cheung AN; Ngan HY
    Br J Cancer; 2006 Oct; 95(8):1087-91. PubMed ID: 17047655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
    Mayr D; Hirschmann A; Löhrs U; Diebold J
    Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant mucinous ovarian tumor with low malignant potential with foci of well-differentiated mucinous adenocarcinoma masked by massive obesity. A case report.
    Poole SY; Malone JM; Jacques SM; James A
    J Reprod Med; 1994 Dec; 39(12):982-4. PubMed ID: 7884758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of a mature teratoma and mucinous cystadenocarcinoma in the same ovary--a case report.
    Ray S; Anuradha D; Barui G; Karmakar R; Sinha A; Bhattacharya A
    Indian J Pathol Microbiol; 2006 Jul; 49(3):420-2. PubMed ID: 17001907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian mucinous cystadenocarcinoma with virilization.
    Nezhat F; Slomovitz BM; Saiz AD; Cohen CJ
    Gynecol Oncol; 2002 Mar; 84(3):468-72. PubMed ID: 11855891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-existent ovarian mucinous cystadenocarcinoma and ovarian choriocarcinoma.
    Jiménez-Heffernan JA; Perna C; Martínez A; Casinello J; Cuevas J
    Arch Gynecol Obstet; 2002 Aug; 266(4):235-7. PubMed ID: 12192487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endometrioid adenocarcinoma of the uterine cervix associated with mucinous ovarian cystadenocarcinoma].
    Ferchichi L; Rammeh-Rommani S; Ben Hammouda S; Sfar R; Farah F; Ben Jilani S; Zermani R
    Gynecol Obstet Fertil; 2006 May; 34(5):410-2. PubMed ID: 16677843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dedifferentiation in a mucinous tumour of the ovary.
    Rekha W; Amita M; Sudeep G; Shubadha K; Hemant T
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):172. PubMed ID: 15760327
    [No Abstract]   [Full Text] [Related]  

  • 16. Krukenberg tumor of ovary with features of mucinous cystadenocarcinoma.
    Thomas S; Chandi SM
    Indian J Cancer; 1999; 36(2-4):205-7. PubMed ID: 10921229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucinous cystadenocarcinoma arising in mature cystic teratoma ovary and associated pseudomyxoma peritonei: report of a case.
    Mandal S; Kawatra V; Khurana N
    Arch Gynecol Obstet; 2008 Sep; 278(3):265-7. PubMed ID: 18293005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastasis of breast carcinoma to a primary mucinous cystadenocarcinoma of the ovary.
    Twaalfhoven FC; Fleuren GJ; Cornelisse CJ; Peters AA; Trimbos JB; Hogendoorn PC
    Gynecol Oncol; 1994 Jan; 52(1):80-6. PubMed ID: 8307506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian mucinous cystadenocarcinoma of low malignant potential associated with a mature cystic teratoma.
    Al-Ghamdi FA; Al-Khattabi MA
    Saudi Med J; 2006 Sep; 27(9):1412-4. PubMed ID: 16951785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interphase cytogenetic analysis of mucinous ovarian neoplasms.
    Diebold J; Siegert S; Baretton GB; Suchy B; Meier W; Haas CJ; Löhrs U
    Lab Invest; 1997 May; 76(5):661-70. PubMed ID: 9166285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.